Female Fertility and Pregnancy Rapid Test Market: Current Analysis and Forecast (2021-2027)
Emphasis on Device Type (Digital Devices and Line-indicator Devices); Test Type (FSH Urine Test, LH Urine Test, hCG Blood Test, and hCG Urine Test); Product (Fertility Rapid Test Kits and Pregnancy Rapid Test Kits); Distribution channel (Retail Stores, Online Stores, Gynecology and Fertility Clinics, and Others) and Region/Country
The global female fertility and pregnancy rapid test market is experiencing significant growth due to the increasing aging population and fast and self-contained tests, and awareness regarding the safety of women’s health among consumers. For Instance, in June 2021, BioMerieux announced the distribution of specific diagnostics’ REVEAL Rapid AST system in Europe which strengthen the rapid testing kits segment of the market in the European region. The specific reveal rapid AST system delivers phenotypic AST results in an average of 5 hours, directly from positive blood culture. Thus, with the growing focus on technology the specific reveal is easy to use, has high throughput, and provides accurate minimum inhibitory concentration (MIC) results with wide antimicrobial coverage. Furthermore, REVEAL Rapid AST offers customers an easy-to-use instrument with a targeted menu, small footprint, and modular design well-suited for many hospitals. Therefore, the market for female fertility and pregnancy rapid tests is expected to witness a significant CAGR of 5.5% during the forecast period.
Global female fertility and pregnancy rapid test market is expected to register a CAGR of around 5% over the period of 2021-2027. This is mainly due to the rapid advancement in technology and rises in first-time pregnancy age and the availability of less time-consuming reorganized diagnostic tests in place of laboratory tests are responsible for the market growth of female fertility and pregnancy rapid tests. Furthermore, the increasing adoption of home-based diagnostic testing products significantly contributes to the market for testing devices. According to the OECD, the average age at which women give birth now stands at 30 or above; this trend is majorly being observed as women across the globe are showcasing a greater preference for postponing first-time pregnancies. Moreover, the increasing elderly population of the country is also responsible for boosting the market for female fertility and pregnancy rapid tests. The demand for female fertility and pregnancy rapid test products also increased due to the rising prevalence of medical conditions like hormonal imbalance in females such as irregular and heavy bleeding, indescribable miscarriages, and abnormalities of the uterus which is responsible for excessive use of female fertility and pregnancy rapid tests and significantly contributes to the market for these devices. Therefore, the market for female fertility and pregnancy rapid tests is expected to witness significant growth during the forecast period.
BioMerieux, Abbott, Church & Dwight, Quidel, Clinical Guard, Fairhaven Health, PRIMA Lab, Princeton BioMeditech, Wondfo, and Mankind Pharma are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst Test Type, LH urine test category accounted for the majority share in the market in 2020”
Based on test type, the market is classified into FSH urine test, LH urine test, hCG blood test, and hCG urine test. Amongst types, the LH urine test category accounted for a significant share of the market. This is mainly due to the high level of LH indicates that the release of the egg (ovulation) usually occurs 12-24 hours after the test turns positive. Over the forthcoming years, the rising popularity of LH urine tests among the younger generation is likely to boost the demand for female fertility and pregnancy rapid tests.
“Amongst Product, pregnancy rapid test kits is expected to witness highest CAGR during the forecast period”
Based on product, the market is categorized into fertility rapid test kits and pregnancy rapid test kits. Among these, pregnancy rapid test kits are expected to witness the highest CAGR during the forecast period. The pregnancy rapid test kits are growing the number of adolescent pregnancies and are expected to support the growth of the segment over the forecast period. These results boost the production of test kits. In due course in males, the detection of the sperm count can be done with the use of fertility rapid test kits. In females, the fertility rapid test kits are used to confirm menopause or to find the exact day of ovulation. The continuous development of the new products and procedures is likely to strengthen the market of the segment during the forecast period.
“North America to witness significant growth during the forecast period”
North America is expected to show significant growth in the female fertility and pregnancy rapid test market. The major contributors to the growth of this market are US and Canada. The increase in technology development in emerging economies, as well as the expansion of the healthcare industry, has contributed to the growth of the North America market. North America has a higher adoption rate of technologically advanced and innovative solutions and devices. The enhanced consumer awareness regarding the availability of various female fertility and pregnancy rapid tests has propelled the growth of the market in the region. Hence these require devices in the region which drives the demand for female fertility and pregnancy rapid tests in the region. Furthermore, increasing geriatric population and new product launches, and various developmental strategies adopted by the regional market will drive market growth. The endorsement of increasing demand for home diagnostic kits also significantly contributed to the considerable growth of the state. Furthermore, as reported by CDC, about 12% of women between the age group 15-44 years of age in the U.S. have difficulty in getting pregnant or carrying a pregnancy.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
Global female fertility and pregnancy rapid test market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Global Female Fertility and Pregnancy Rapid Test Market Analysis (2021-2027)
Analyzing the historical market, estimation of the current market, and forecasting the future market of the global female fertility and pregnancy rapid test market were the three major steps undertaken to create and analyze the adoption of female fertility and pregnancy rapid test in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global female fertility and pregnancy rapid test market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Seek More Details About Research Methodology
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the female fertility and pregnancy rapid test market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the female fertility and pregnancy rapid test market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as device type, test type, product, distribution channel, and region. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the female fertility and pregnancy rapid test market. Further, we conducted factor analysis using dependent and independent variables such as device type, test type, product, distribution channel, and region of female fertility and pregnancy rapid test. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Female fertility and pregnancy rapid test market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global female fertility and pregnancy rapid test market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach were applied to arrive at the market forecast about 2027 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of female fertility and pregnancy rapid test market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global female fertility and pregnancy rapid test market in terms of solutions offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global female fertility and pregnancy rapid test market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of device type, test type, product, distribution channel, and region in the global female fertility and pregnancy rapid test market.
The main objective of the Global Female fertility and pregnancy rapid test Market Study
The current & future market trends of the global female fertility and pregnancy rapid test market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the female fertility and pregnancy rapid test market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of device type, test type, product, distribution channel, and region.
- Define and analysis of the regulatory framework for the female fertility and pregnancy rapid test market industry.
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
- Analyze the current and forecast market size of the female fertility and pregnancy rapid test market for the major region.
- Major countries of regions studied in the report include North America, Europe, Asia Pacific, and Rest of the world.
- Company profiles of the female fertility and pregnancy rapid test market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
